Annals of Clinical Microbiology and Antimicrobials

Papers
(The H4-Index of Annals of Clinical Microbiology and Antimicrobials is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Plasma CRP level is positively associated with the severity of COVID-19178
COVID-19: breaking down a global health crisis174
Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes130
Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review119
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19109
Clinical features, hospitalisation and deaths associated with monkeypox: a systematic review and meta-analysis82
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic76
Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic?59
Venezuelan equine encephalitis virus: the problem is not over for tropical America42
Complications of peritonsillar abscess39
Bacteriophage therapy for inhibition of multi drug‐resistant uropathogenic bacteria: a narrative review38
Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy38
Repurposing of antibiotics for clinical management of COVID-19: a narrative review31
Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study31
Characterisation of antibiotic resistance, virulence, clonality and mortality in MRSA and MSSA bloodstream infections at a tertiary-level hospital in Hungary: a 6-year retrospective study30
Correlation between antimicrobial resistance and biofilm formation capability among Klebsiella pneumoniae strains isolated from hospitalized patients in Iran30
Coagulase-negative staphylococci (CoNS) as a significant etiological factor of laryngological infections: a review30
Changes in the spatial distribution of COVID-19 incidence in Italy using GIS-based maps29
Secondary bacterial infections and antimicrobial resistance in COVID-19: comparative evaluation of pre-pandemic and pandemic-era, a retrospective single center study28
Molecular characteristics of antibiotic-resistant Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized patients in Tehran, Iran27
Antimicrobial susceptibility of gram-positive and gram-negative bacteria: a 5-year retrospective analysis at a multi-hospital healthcare system in Saudi Arabia27
Evaluation of Rapid Sepsityper® protocol and specific MBT-Sepsityper module (Bruker Daltonics) for the rapid diagnosis of bacteremia and fungemia by MALDI-TOF-MS24
Safety and bactericidal efficacy of cold atmospheric plasma generated by a flexible surface Dielectric Barrier Discharge device against Pseudomonas aeruginosa in vitro and in vivo24
Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy23
A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-e23
0.027969837188721